TargED Biopharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $117M

  • Investors
  • 17

TargED Biopharmaceuticals General Information

Description

Developer of biopharmaceutical drugs intended to serve doctors and healthcare professionals to improve the treatment of thrombosis. The company offers small antibody-based therapies that deliver enzymes directly to disease sites, enabling clients to accelerate treatment and enhance patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • VMC Building
  • Princetonlaan 6
  • 3584 CB Utrecht
  • Netherlands
+31 030
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • VMC Building
  • Princetonlaan 6
  • 3584 CB Utrecht
  • Netherlands
+31 030

TargED Biopharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TargED Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A2) 15-Dec-2025 $117M Completed Clinical Trials - Phase 1
8. Accelerator/Incubator Completed Clinical Trials - Phase 1
7. Accelerator/Incubator 30-Jun-2025 Completed Clinical Trials - Phase 1
6. Later Stage VC Completed Pre-Clinical Trials
5. Debt - General 17-Dec-2020 Completed Pre-Clinical Trials
4. Seed Round 24-Nov-2020 Completed Pre-Clinical Trials
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Jan-2018 Completed Startup
1. University Spin-Out 01-Jul-2020 Completed Startup
To view TargED Biopharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TargED Biopharmaceuticals Patents

TargED Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026002965-A1 Methods for preventing or treating tissue damage resulting from a disruption of homeostasis, and active principles for use in the same Pending 24-Jun-2024
AU-2024408267-A1 Targeting and lysing microthrombi associated with aberrant blood clotting Pending 19-Dec-2023
EP-4828978-A1 Targeting and lysing microthrombi associated with aberrant blood clotting Pending 19-Dec-2023
US-20260125665-A1 Targeting and lysing microthrombi associated with aberrant blood clotting Pending 19-Dec-2023
EP-4519324-A1 Single domain antibodies for the detection of plasmin-cleaved vwf Pending 02-May-2022 C07K16/36
To view TargED Biopharmaceuticals’s complete patent history, request access »

TargED Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TargED Biopharmaceuticals Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andera Partners PE/Buyout Minority
Fund+ Venture Capital Minority
Hadean Ventures Venture Capital Minority
Inkef Venture Capital Minority
Kurma Partners Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

TargED Biopharmaceuticals FAQs

  • When was TargED Biopharmaceuticals founded?

    TargED Biopharmaceuticals was founded in 2018.

  • Where is TargED Biopharmaceuticals headquartered?

    TargED Biopharmaceuticals is headquartered in Utrecht, Netherlands.

  • What is the size of TargED Biopharmaceuticals?

    TargED Biopharmaceuticals has 33 total employees.

  • What industry is TargED Biopharmaceuticals in?

    TargED Biopharmaceuticals’s primary industry is Drug Discovery.

  • Is TargED Biopharmaceuticals a private or public company?

    TargED Biopharmaceuticals is a Private company.

  • What is TargED Biopharmaceuticals’s current revenue?

    The current revenue for TargED Biopharmaceuticals is .

  • How much funding has TargED Biopharmaceuticals raised over time?

    TargED Biopharmaceuticals has raised $119M.

  • Who are TargED Biopharmaceuticals’s investors?

    Andera Partners, Fund+, Hadean Ventures, Inkef, and Kurma Partners are 5 of 17 investors who have invested in TargED Biopharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process